Pain Therapeutics, Inc. (PTIE)


Pain Therapeutics, Inc. (PTIE)

$1.24 USD

0.08 (6.90%)

Updated Mar 27 7:41pm

Add PTIE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 321 in Biotech

See all “A” rated Strong Buy stocks

PTIE Daily Price Range
PTIE 52-Week Price Range

PTIE News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All PTIE News

Pain Therapeutics, Inc. (PTIE) Company Bio


Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs in the United States. The company’s lead drug candidate is REMOXY, a proprietary abuse-deterrent oral formulation of oxycodone for pain relief. It also develops FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; and PTI-125, a small molecule drug candidate to treat Alzheimer’s disease and other neurological disorders. The company was founded in 1998 and is based in Austin, Texas.

PTIE Stock Chart More Charts


PTIE Price/Volume Stats

Current price $1.24
Prev. close $1.16
Day low $1.18
Day high $1.27
50-day MA $1.17
200-day MA $1.79
52-week high $10.87
52-week low $0.76
Volume 294,500
Avg. volume 285,037
Dividend yield N/A
Market Cap 21.35M

PTIE Social Stream


Loading social stream, please wait...

View Full PTIE Social Stream

PTIE Returns

1-mo N/A
3-mo N/A
6-mo 6.90%
1-year -43.89%
3-year -51.37%
5-year -74.17%
YTD 45.88%
2018 -78.75%
2017 601.75%
2016 -67.43%
2015 -13.79%
2014 -58.23%


Page generated in 0.5407 seconds.